Overview
Collaborative Drug Discovery (CDD) was established in 2004 when founder & CEO Barry Bunin was an entrepreneur in residence at Eli Lilly & Co. Its product–CDD Vault is a hosted scientific data management platform that gives drug discovery teams a single, trusted system for storing, analyzing, and sharing research data. The software application replaces the fragmented spreadsheets, siloed notebooks, complex data room configurations and disconnected tools that slow science down.
Built by scientists and purpose-built for both small molecules and biological therapeutics (siRNA, ASOs, peptides, antibodies and ADCs), CDD Vault now brings chemically aware structure handling to biologics alongside its proven medicinal chemistry capabilities, so teams working across modalities can collaborate more effectively. Whether optimizing small molecule leads or characterizing biological therapeutics, CDD Vault integrates your Electronic Lab Notebook (ELN), Registration, and SAR analysis into one secure intuitive platform alongside accessible visualization tools, comprehensive curve fitting algorithms and a RESTful API.
CDD Vault was designed to meet FAIR data standards and structured to scale to help teams move faster—reducing administrative burden and providing a secure and robust foundation for AI-driven discovery and investor-ready reporting. From small startups building the data story for investors to distributed organizations aligning global teams including CROs, CDD Vault acts as the data foundation for early-stage research.
Learn more at www.collaborativedrug.com